R Pallanza
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus
- Tuberculosis Research and Epidemiology
Papers in
- Pharmacology 11
- Antibiotics Pharmacokinetics and Efficacy 6
- Microbial Natural Products and Biosynthesis 4
- Co-authors
- S FürészRoberto ScottiM BertiV. ARIOLIAdriano MalabarbaN. MaggiL. G. SilvestriGiancarlo Lancini
In The Last Decade
R Pallanza
28 papers receiving 466 citations
Peers
Comparison fields: 5 of 71
- Molecular Medicine 91
- Infectious Diseases 214
- Pharmacology 194
- Microbiology 7
- Microbiology 47
Countries citing papers authored by R Pallanza
This map shows the geographic impact of R Pallanza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Pallanza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Pallanza more than expected).
Fields of papers citing papers by R Pallanza
This network shows the impact of papers produced by R Pallanza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Pallanza. The network helps show where R Pallanza may publish in the future.
Co-authors
The 25 scholars most cited alongside R Pallanza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 6 | |
| 2 | 1992 | 24 | |
| 3 | 1990 | 6 | |
| 4 | 1990 | 18 | |
| 5 | 1989 | 8 | |
| 6 | 1989 | 14 | |
| 7 | 1989 | 9 | |
| 8 | 1989 | 36 | |
| 9 | 1989 | 6 | |
| 10 | 1988 | 12 | |
| 11 | 1987 | 14 | |
| 12 | 1985 | 18 | |
| 13 | 1984 | 4 | |
| 14 | 1-Alkyl-2-nitroimidazol-5-yl derivatives. I. | 1975 | 1 |
| 15 | Rifampicin and immunosuppression. | 1974 | 8 |
| 16 | 1968 | 22 | |
| 17 | Rifampicin: a new rifamycin. II. Laboratory studies on the antituberculous activity and preliminary clinical observations. | 1967 | 40 |
| 18 | New derivatives of rifamycin SV. | 1965 | 32 |
| 19 | Antimicrobial properties of new derivatives of rifamycin SV. | 1965 | 17 |
| 20 | 1964 | 20 |
About R Pallanza
R Pallanza is a scholar working on Microbiology, Pharmacology, Molecular Medicine, Microbiology and Infectious Diseases, having authored 28 papers that have together received 614 indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (7 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Microbial Natural Products and Biosynthesis (4 papers), Natural product bioactivities and synthesis (4 papers), Synthesis of β-Lactam Compounds (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers) and Tuberculosis Research and Epidemiology (3 papers). The work is most often cited by research in Molecular Medicine (91 citations), Infectious Diseases (214 citations), Pharmacology (194 citations), Microbiology (7 citations) and Microbiology (47 citations). R Pallanza has collaborated with scholars based in Italy and China. Frequent co-authors include S Fürész, Roberto Scotti, M Berti, V. ARIOLI, Adriano Malabarba, N. Maggi, L. G. Silvestri, Giancarlo Lancini, Beth P. Goldstein and Pietro Ferrari. Their work appears in journals such as The Journal of Antibiotics, Journal of Medicinal Chemistry, Journal of Bacteriology, Gut and Cellular and Molecular Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.